Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
Bailliere'S Clinical Haematology
|
March 1, 1994
Cytokine gene transfer in the therapy of malignancy
H E Heslop
British Journal of Haematology
|
June 12, 1999
Haemopoietic stem cell transplantation from unrelated donors
H E Heslop
Clinics in Laboratory Medicine
|
March 7, 2000
Gene therapy of pediatric leukemia
H E Heslop
Journal of Immunological Methods
|
January 1, 1978
A method for preparing leucocyte depleted erythrocytes from rat blood
H E Heslop
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 22, 2001
Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation
H E Heslop
Cytotherapy
|
September 21, 2007
Gene therapy
H E Heslop
Cytotherapy
|
August 6, 2005
Current status of genetic modification of T cells for cancer treatment
G Dotti, H E Heslop
Bone Marrow Transplantation
|
May 12, 2015
Engineering haploidentical transplants
S Naik, H E Heslop
Current Opinion in Hematology
|
November 1, 1995
Gene transfer for the therapy of hematologic malignancy
H E Heslop, M Roskrow
Cytotherapy
|
July 10, 2003
Is retroviral gene marking too dangerous to use?
M K Brenner, H E Heslop
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
Bailliere'S Clinical Haematology
|
March 1, 1994
Cytokine gene transfer in the therapy of malignancy
H E Heslop
British Journal of Haematology
|
June 12, 1999
Haemopoietic stem cell transplantation from unrelated donors
H E Heslop
Clinics in Laboratory Medicine
|
March 7, 2000
Gene therapy of pediatric leukemia
H E Heslop
Journal of Immunological Methods
|
January 1, 1978
A method for preparing leucocyte depleted erythrocytes from rat blood
H E Heslop
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 22, 2001
Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation
H E Heslop
Cytotherapy
|
September 21, 2007
Gene therapy
H E Heslop
Cytotherapy
|
August 6, 2005
Current status of genetic modification of T cells for cancer treatment
G Dotti, H E Heslop
Bone Marrow Transplantation
|
May 12, 2015
Engineering haploidentical transplants
S Naik, H E Heslop
Current Opinion in Hematology
|
November 1, 1995
Gene transfer for the therapy of hematologic malignancy
H E Heslop, M Roskrow
Cytotherapy
|
July 10, 2003
Is retroviral gene marking too dangerous to use?
M K Brenner, H E Heslop
Page
of 14